PW Medtech Group Limited
HKEX:1358.HK
1.04 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 675.084 | 536.826 | 271.399 | 247.352 | 362.183 | 310.813 | 286.913 | 319.583 | 515.587 | 608.059 | 457.083 | 331.541 |
| Cost of Revenue
| 294.187 | 238.001 | 105.343 | 98.748 | 140.056 | 115.57 | 112.386 | 109.277 | 129.17 | 165.17 | 146.656 | 112.694 |
| Gross Profit
| 380.897 | 298.825 | 166.056 | 148.604 | 222.127 | 195.243 | 174.527 | 210.306 | 386.417 | 442.889 | 310.427 | 218.847 |
| Gross Profit Ratio
| 0.564 | 0.557 | 0.612 | 0.601 | 0.613 | 0.628 | 0.608 | 0.658 | 0.749 | 0.728 | 0.679 | 0.66 |
| Reseach & Development Expenses
| 41.13 | 40.975 | 20.253 | 48.195 | 27.942 | 29.334 | 13.114 | 11.713 | 23.898 | 47.05 | 26.49 | 9.512 |
| General & Administrative Expenses
| 119.02 | 122.098 | 61.31 | 56.545 | 65.24 | 58.086 | 70.56 | 44.491 | 61.526 | 79.2 | 59.297 | 35.603 |
| Selling & Marketing Expenses
| 76.086 | 67.471 | 61.779 | 82.67 | 101.157 | 72.917 | 54.785 | 41.696 | 68.563 | 94.224 | 61.942 | 46.821 |
| SG&A
| 195.106 | 189.569 | 123.089 | 148.986 | 181.894 | 116.924 | 125.345 | 86.956 | 130.089 | 174.223 | 121.539 | 82.424 |
| Other Expenses
| 26.513 | 24.212 | 20.659 | 9.695 | 16.712 | -25.325 | 0.121 | 0.366 | 1.242 | 0.553 | 1.01 | 0.199 |
| Operating Expenses
| 218.283 | 175.982 | 514.678 | 483.121 | 107.821 | 61.458 | 131.22 | 84.706 | 146.035 | 238.051 | 196.344 | 87.222 |
| Operating Income
| 187.396 | 98.167 | 47.068 | -24.688 | 40.861 | 61.808 | 44.701 | 117.526 | 239.692 | 239.787 | 172.404 | 128.481 |
| Operating Income Ratio
| 0.278 | 0.183 | 0.173 | -0.1 | 0.113 | 0.199 | 0.156 | 0.368 | 0.465 | 0.394 | 0.377 | 0.388 |
| Total Other Income Expenses Net
| 39.228 | 59.58 | 690.396 | 651.287 | 44.947 | 64.767 | 0.38 | 10.317 | 5.685 | -28.465 | -58.541 | -8.76 |
| Income Before Tax
| 231.067 | 157.747 | 737.464 | 626.599 | 85.808 | 126.575 | 45.081 | 127.843 | 245.377 | 211.322 | 113.863 | 119.721 |
| Income Before Tax Ratio
| 0.342 | 0.294 | 2.717 | 2.533 | 0.237 | 0.407 | 0.157 | 0.4 | 0.476 | 0.348 | 0.249 | 0.361 |
| Income Tax Expense
| 26.044 | 28.88 | 1.653 | 5.212 | 3.839 | 11.064 | 11.304 | 20.21 | 41.15 | 34.692 | 22.86 | 19.538 |
| Net Income
| 153.184 | 106.041 | 739.12 | 631.814 | 81.982 | 114.812 | 4.519 | 109.136 | 208.582 | 176.63 | 77.905 | 44.668 |
| Net Income Ratio
| 0.227 | 0.198 | 2.723 | 2.554 | 0.226 | 0.369 | 0.016 | 0.341 | 0.405 | 0.29 | 0.17 | 0.135 |
| EPS
| 0.098 | 0.068 | 0.47 | 0.4 | 0.052 | 0.073 | 0.003 | 0.067 | 0.12 | 0.11 | 0.062 | 0.04 |
| EPS Diluted
| 0.098 | 0.068 | 0.47 | 0.4 | 0.052 | 0.073 | 0.003 | 0.067 | 0.12 | 0.1 | 0.061 | 0.04 |
| EBITDA
| 334.643 | 175.49 | 77.98 | 2.942 | 69.271 | 81.845 | 64.423 | 137.153 | 297.669 | 277.956 | 192.814 | 141.496 |
| EBITDA Ratio
| 0.496 | 0.327 | 0.287 | 0.012 | 0.191 | 0.263 | 0.225 | 0.429 | 0.577 | 0.457 | 0.422 | 0.427 |